GAIL ECKHARDT to Drug Resistance, Neoplasm
This is a "connection" page, showing publications GAIL ECKHARDT has written about Drug Resistance, Neoplasm.
Connection Strength
0.136
-
A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Ann Oncol. 2018 07 01; 29(7):1561-1568.
Score: 0.113
-
A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer. Int J Cancer. 2016 Jan 01; 138(1):195-205.
Score: 0.023